Home
Who We Are
Overview
Management
Board of Directors
What We Do
Overview
Bertilimumab
NanoCyclo
AmiKetâ„¢ / AmiKet Nano
Oncology
Investor Information
Overview
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
News & Events
Press Releases
Events
News
Contact
Search
Search Terms
News
Press Releases
Events
News
Immune CEO Daniel Teper answers Cytovia questions in an interview with Jane King
February 23, 2017
Watch our latest interview with Immune CEO Daniel Teper and Jane King